18 and older, any sex, with Enteral Feeding. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Volume of Enteral Feed Consumed Per DayPrimary· 14 days
Volume in mls of enteral feed consumed in total, and with Mobility+
Volume in milliliters of enteral feed consumed (Mobility+)
Group
Value
95% CI
Patient Cohort
1050
± 363
Volume in milliliters of enteral feed consumed (other EN systems)
Group
Value
95% CI
Patient Cohort
256
± 294
Patient Perspective on Mobility Using Current Enteral Feeding System vs Mobility+Secondary· 14 days
Subjective scale (Likert) - Ease of performing activities during feeding rated as: Very easy (5), Easy (4), Neutral (3), Difficult (2), Very difficult (1).
Moving from one room to another (Baseline)
Group
Value
95% CI
Patient Cohort
2.6
± 1.2
Moving from one room to another (End of Study post 14 d feeding w/ Mobility+ (Day 21))
Group
Value
95% CI
Patient Cohort
4.6
± 0.5
Going up and down stairs (Baseline)
Group
Value
95% CI
Patient Cohort
2.1
± 1.3
Going up and down stairs (End of Study post 14 d feeding w/ Mobility+ (Day 21))
Group
Value
95% CI
Patient Cohort
4.6
± 0.5
Short walk (e.g 1 block) (Baseline)
Group
Value
95% CI
Patient Cohort
2.3
± 1.2
Short walk (e.g. 1 block) (End of Study post 14 d feeding w/ Mobility+ (Day 21))
Group
Value
95% CI
Patient Cohort
4.5
± 0.6
Long walk (e.g. several blocks) (Baseline)
Group
Value
95% CI
Patient Cohort
1.9
± 1.1
Long walk (e.g. several blocks) (End of Study post 14 d feeding w/ Mobility+ (Day 21))
Group
Value
95% CI
Patient Cohort
4.4
± 0.7
Patient Perspective on Ease of Use Using Current Enteral Feeding System and Mobility+Secondary· 14 days
Subjective scale (Likert) - Ease of use of current enteral feeding systems and Mobility+ were rated as: Strongly agree (5), Somewhat agree (4), Neutral (3), Somewhat disagree (2), Strongly disagree (1).
System is easy to use (Baseline)
Group
Value
95% CI
Patient Corhort
3.8
± 0.8
System is easy to use (End of Study post 14 d feeding w/ Mobility+ (Day 21))
Group
Value
95% CI
Patient Corhort
3.5
± 1.5
System is easy to carry (Baseline)
Group
Value
95% CI
Patient Corhort
2.8
± 1.4
System is easy to carry (End of Study post 14 d feeding w/ Mobility+ (Day 21))
Group
Value
95% CI
Patient Corhort
4.2
± 1.0
The noise level of system is acceptable (Baseline)
Group
Value
95% CI
Patient Corhort
4.2
± 1.2
The noise level of system is acceptable (End of Study post 14 d feeding w/ Mobility+ (Day 21))
Group
Value
95% CI
Patient Corhort
4.8
± 0.5
System allows me to feed discreetly (Baseline)
Group
Value
95% CI
Patient Corhort
1.9
± 1.2
System allows me to feed discreetly (End of Study post 14 d feeding w/ Mobility+ (Day 21))
Group
Value
95% CI
Patient Corhort
3.6
± 1.3
Participant Perspective on Quality of LifeSecondary· 14 days
Subjective scale (Likert) - Perspective on Quality of Life rated as: Excellent (5), Good (4), Neutral (3), Bad (2), Very bad (1)
Quality of life (participant perspective) at baseline
Group
Value
95% CI
Patient Cohort
3.6
± 0.9
Quality of life (participant perspective) at end of Study, post 14 d feeding w/ Mobility+ (Day 21)
Group
Value
95% CI
Patient Cohort
3.7
± 0.8
Usability of Mobility+ (Volume)Secondary· 14 days
Estimate if participants consume similar average volume of feed/day during the study, compared to baseline
Total enteral feed volume consumed per day at baseline
Group
Value
95% CI
Patient Cohort
1174
± 353
Total enteral feed volume consumed per day at end of Study, post 14 d feeding w/ Mobility+ (Day 21))
Group
Value
95% CI
Patient Cohort
1306
± 318
Total enteral feed kcal consumed per day, at baseline
Group
Value
95% CI
Patient Cohort
1848
± 604
Total enteral feed kcal consumed per day, at study end, post 14 d feeding w/ Mobility+ (Day 21))
Group
Value
95% CI
Patient Cohort
2034
± 527
Usability of Mobility+ (kcal)Secondary· 14 days
Estimate if participants consume similar average kcals of feed/day during the study, compared to baseline
Total enteral feed kcal consumed per day, at baseline
Group
Value
95% CI
Patient Cohort
1848
± 604
Total enteral feed kcal consumed per day, at study end, post 14 d feeding w/ Mobility+ (Day 21))
Group
Value
95% CI
Patient Cohort
2034
± 527
Sponsor's own description
The goal of this interventional study is to obtain information on the safety and effectiveness of a novel enteral feeding system in adult users requiring at least a portion of their nutritional intake via enteral feeding. The main questions it aims to answer are:
* Can the device be used safely and effectively?
* Does use of the device impact on patient's quality of life?
Participants will use Mobility+ enteral feeding system as their enteral feeding method for the duration of the study and will record their experiences.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rockfield Medical Devices
Last refreshed: 29 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06173063.